Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

J. Alexander Bodkin, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Barnett BS, Bodkin JA. A Survey of American Psychiatrists Concerning Medication Prior Authorization Requirements. J Nerv Ment Dis. 2020 Jul; 208(7):566-573. PMID: 32604163.
    Citations:    
  2. Thase ME, Stanford AD, Memisoglu A, Martin W, Claxton A, Bodkin JA, Trivedi MH, Fava M, Yu M, Pathak S. Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder. Neuropsychopharmacology. 2019 12; 44(13):2268-2276. PMID: 31254971.
    Citations:    
  3. Barnett BS, Bodkin JA. Clinician Time Expended Obtaining Prior Authorizations for Behavioral Health Admissions. Psychiatr Serv. 2019 06 01; 70(6):533-534. PMID: 31154963.
    Citations:    
  4. Bodkin JA, Coleman MJ, Godfrey LJ, Carvalho CMB, Morgan CJ, Suckow RF, Anderson T, Öngür D, Kaufman MJ, Lewandowski KE, Siegel AJ, Waldstreicher E, Grochowski CM, Javitt DC, Rujescu D, Hebbring S, Weinshilboum R, Rodriguez SB, Kirchhoff C, Visscher T, Vuckovic A, Fialkowski A, McCarthy S, Malhotra D, Sebat J, Goff DC, Hudson JI, Lupski JR, Coyle JT, Rudolph U, Levy DL. Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene. Biol Psychiatry. 2019 10 01; 86(7):523-535. PMID: 31279534.
    Citations:    
  5. Saxena PP, Bodkin JA. Opioidergic Agents as Antidepressants: Rationale and Promise. CNS Drugs. 2019 01; 33(1):9-16. PMID: 30430396.
    Citations:    
  6. Morgan CJ, Coleman MJ, Ulgen A, Boling L, Cole JO, Johnson FV, Lerbinger J, Bodkin JA, Holzman PS, Levy DL. Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls. Schizophr Bull. 2017 05 01; 43(3):523-535. PMID: 28338967.
    Citations:    Fields:    Translation:Humans
  7. Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E. Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry. 2016 May 01; 173(5):499-508. PMID: 26869247.
    Citations: 17     Fields:    Translation:Humans
  8. Deutsch CK, Levy DL, Price SF, Bodkin JA, Boling L, Coleman MJ, Johnson F, Lerbinger J, Matthysse S, Holzman PS. Quantitative Measures of Craniofacial Dysmorphology in a Family Study of Schizophrenia and Bipolar Illness. Schizophr Bull. 2015 Nov; 41(6):1309-16. PMID: 25795453.
    Citations: 2     Fields:    Translation:Humans
  9. Silverman BC, Asby A, Brendel DH, Choras P, Chu JA, Holman J, Pope HG, Radden J, Samson JA, Smith GW, Tsimprea G, Bodkin JA. Psychiatric treatment of the VIP: some paradoxical risks. J Nerv Ment Dis. 2012 Jun; 200(6):545-8. PMID: 22652622.
    Citations:    Fields:    Translation:Humans
  10. Pae CU, Bodkin JA, Portland KB, Thase ME, Patkar AA. Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures. J Clin Psychiatry. 2012 May; 73(5):661-8. PMID: 22697192.
    Citations: 6     Fields:    Translation:Humans
  11. Bodkin JA, Allgulander C, Llorca PM, Spann ME, Walker DJ, Russell JM, Ball SG. Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorder. Hum Psychopharmacol. 2011 Apr; 26(3):258-66. PMID: 21678494.
    Citations:    Fields:    Translation:HumansPHPublic Health
  12. Krause V, Krastoshevsky O, Coleman MJ, Bodkin JA, Lerbinger J, Boling L, Johnson F, Gibbs A, Cole JO, Huang Z, Mendell NR, Levy DL. Tailoring the definition of the clinical schizophrenia phenotype in linkage studies. Schizophr Res. 2010 Feb; 116(2-3):133-42. PMID: 19944571.
    Citations: 2     Fields:    Translation:Humans
  13. Llorca PM, Bodkin JA, Spann M, Ball SG, Russell JM, Ball SG. A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design. J Clin Psychopharmacol. 2009 Feb; 29(1):96-7. PMID: 19142122.
    Citations:    Fields:    Translation:HumansPHPublic Health
  14. Bodkin JA, Bacskay GB, McLeod MD. The Sharpless asymmetric aminohydroxylation reaction: optimising ligand/substrate control of regioselectivity for the synthesis of 3- and 4-aminosugars. Org Biomol Chem. 2008 Jul 21; 6(14):2544-53. PMID: 18600276.
    Citations: 1     Fields:    Translation:Cells
  15. Brendel DH, Chu J, Radden J, Leeper H, Pope HG, Samson J, Tsimprea G, Bodkin JA. The price of a gift: an approach to receiving gifts from patients in psychiatric practice. Harv Rev Psychiatry. 2007 Mar-Apr; 15(2):43-51. PMID: 17454174.
    Citations: 2     Fields:    Translation:Humans
  16. Amsterdam JD, Bodkin JA. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial. J Clin Psychopharmacol. 2006 Dec; 26(6):579-86. PMID: 17110814.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  17. Bodkin JA, Pope HG, Detke MJ, Hudson JI. Is PTSD caused by traumatic stress? J Anxiety Disord. 2007; 21(2):176-82. PMID: 17055216.
    Citations: 10     Fields:    Translation:Humans
  18. Coen M, Bodkin J, Power D, Bubb WA, Himmelreich U, Kuchel PW, Sorrell TC. Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy. Antimicrob Agents Chemother. 2006 Dec; 50(12):4018-26. PMID: 16982786.
    Citations: 2     Fields:    Translation:Animals
  19. Bodkin JA, Siris SG, Bermanzohn PC, Hennen J, Cole JO. Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia. Am J Psychiatry. 2005 Feb; 162(2):388-90. PMID: 15677608.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  20. Noyes R, Woodman CL, Bodkin JA, Yagla SJ. Hypochondriacal concerns in panic disorder and major depressive disorder: a comparison. Int J Psychiatry Med. 2004; 34(2):143-54. PMID: 15387398.
    Citations:    Fields:    Translation:Humans
  21. Bodkin JA, Amsterdam JD. Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients. Am J Psychiatry. 2002 Nov; 159(11):1869-75. PMID: 12411221.
    Citations: 30     Fields:    Translation:HumansCTClinical Trials
  22. Brendel DH, Bodkin JA, Hauptman B, Ornstein A. "I see dead people": overcoming psychic numbness. Harv Rev Psychiatry. 2002 May-Jun; 10(3):166-78. PMID: 12023931.
    Citations:    Fields:    Translation:Humans
  23. Brendel DH, Bodkin JA, Yang JM. Massive sertraline overdose. Ann Emerg Med. 2000 Nov; 36(5):524-6. PMID: 11054208.
    Citations: 1     Fields:    Translation:Humans
  24. Pope HG, Oliva PS, Hudson JI, Bodkin JA, Gruber AJ. Attitudes toward DSM-IV dissociative disorders diagnoses among board-certified American psychiatrists. Am J Psychiatry. 1999 Feb; 156(2):321-3. PMID: 9989574.
    Citations: 3     Fields:    Translation:Humans
  25. Davidoff SA, Forester BP, Ghaemi SN, Bodkin JA. Effect of video self-observation on development of insight in psychotic disorders. J Nerv Ment Dis. 1998 Nov; 186(11):697-700. PMID: 9824172.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  26. Pillay SS, Bodkin JA, Shapiro ER. Psychotic acts: the question of meaning. Harv Rev Psychiatry. 1998 May-Jun; 6(1):38-43. PMID: 10370431.
    Citations:    Fields:    Translation:Humans
  27. Pope HG, Hudson JI, Bodkin JA, Oliva P. Questionable validity of 'dissociative amnesia' in trauma victims. Evidence from prospective studies. Br J Psychiatry. 1998 Mar; 172:210-5; discussion 216-7. PMID: 9614469.
    Citations: 3     Fields:    Translation:Humans
  28. Bodkin JA, Lasser RA, Wines JD, Gardner DM, Baldessarini RJ. Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry. 1997 Apr; 58(4):137-45. PMID: 9164423.
    Citations: 21     Fields:    Translation:Humans
  29. Bodkin JA, Cohen BM, Salomon MS, Cannon SE, Zornberg GL, Cole JO. Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine. J Nerv Ment Dis. 1996 May; 184(5):295-301. PMID: 8627275.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  30. Bodkin JA, Klitzman RL, Pope HG. Treatment orientation and associated characteristics of North American academic psychiatrists. J Nerv Ment Dis. 1995 Dec; 183(12):729-35. PMID: 8522933.
    Citations: 1     Fields:    Translation:Humans
  31. Bodkin JA, Zornberg GL, Lukas SE, Cole JO. Buprenorphine treatment of refractory depression. J Clin Psychopharmacol. 1995 Feb; 15(1):49-57. PMID: 7714228.
    Citations: 52     Fields:    Translation:HumansCTClinical Trials
  32. Zornberg GL, Bodkin JA, Cohen BM. Severe adverse interaction between pethidine and selegiline. Lancet. 1991 Jan 26; 337(8735):246. PMID: 1670882.
    Citations: 17     Fields:    Translation:Humans
  33. Bodkin JA. Emerging uses for high-potency benzodiazepines in psychotic disorders. J Clin Psychiatry. 1990 May; 51 Suppl:41-6; discussion 50-3. PMID: 1970817.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  34. Cole JO, Bodkin JA. Antidepressant drug side effects. J Clin Psychiatry. 1990 Jan; 51 Suppl:21-6. PMID: 2404000.
    Citations: 2     Fields:    Translation:Humans
  35. Bodkin JA, White K. Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient. J Clin Psychiatry. 1989 Jul; 50(7):265-6. PMID: 2738031.
    Citations: 5     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Bodkin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (190)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.